Dr. Thomas E Kennedy

M.D. | Neurology


  3841 Piper St, Ste T345, Anchorage
     Alaska, 99508-4624
  907-565-6000    866-977-2562 Maps & Directions
Dr. Thomas E Kennedy is a Anchorage, Alaska based neurologist who is specialized in Neurology. His current practice location is 3841 Piper St, Ste T345, Anchorage. Patients can reach him at 907-565-6000 or can fax him at 866-977-2562. Dr. Thomas E Kennedy is M.D. in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1225058951.
Dr. Thomas E Kennedy specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Dr. Thomas E Kennedy speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Dr. Thomas E Kennedy
Specialization: Neurology
Gender:Male
Credentials: M.D.
Practice Address:3841 Piper St, Ste T345, Anchorage,
Alaska, 99508-4624
Phone:907-565-6000
Fax:866-977-2562
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1225058951
NPI Enumeration Date: 19 Jul, 2006
NPI Last Update On: 22 Apr, 2013

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Dr. Thomas E Kennedy
3841 Piper St, Ste T345
Anchorage, Alaska
Zip: 99508-4624
Phone Number: 907-565-6000
Fax Number: 866-977-2562
Patients can reach Dr. Thomas E Kennedy at 3841 Piper St, Ste T345, Anchorage, Alaska or can call to book an appointment on 907-565-6000.
Comments/ Reviews:

Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.